CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CERo Therapeutics Holdings, Inc. is a biotech firm dedicated to pioneering advanced engineered T-cell immunotherapies for the treatment of various cancers. Their leading therapeutic candidate, CER-1236, is an autologous T-cell therapy currently in development, aimed at addressing both blood cancers (hematologic malignancies) and solid tumors. This company was founded in 2021 and is headquartered in South San Francisco, California.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
CERo Therapeutics Holdings, Inc.
- Not computed: short interest % needs a single float figure, and the float on record is a bound or estimate.
- 20.2K
- 1.00
The cost to borrow CERO shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.
- 70.4%
- 977
Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.
Latest short interest settlements (today's share basis)
| Date | Shares short |
|---|---|
| Oct 30, 2026 | 20.2K sh |
| Oct 15, 2026 | 1.0K sh |
| Sep 30, 2026 | 12.4K sh |
| Sep 15, 2026 | 2.5K sh |
| Aug 31, 2026 | 36.1K sh |
Latest fails to deliver
| Date | Shares failed |
|---|---|
| Sep 23, 2026 | 977 sh |
| Sep 16, 2026 | 989 sh |
| Sep 15, 2026 | 85 sh |
| Sep 4, 2026 | 651 sh |
| Sep 3, 2026 | 201 sh |
A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.
The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.
Latest sessions
| Date | Reported short |
|---|---|
| Nov 16, 2026 | 70.4% |
| Nov 13, 2026 | 66.0% |
| Nov 12, 2026 | 4.2% |
| Nov 11, 2026 | 0.0% |
| Nov 10, 2026 | 21.1% |
130 calendar days requested; 87 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.
Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.
Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.
FINRA's weekly alternative trading system (dark pool) volume for CERO: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.
As of the Oct 30, 2026 FINRA settlement, 20,236 CERO shares were sold short (1.00 days to cover).